Before it Begins: A Preventative Multi Layer Calcium Driven Framework for Alzheimer’s
CWSF · 2026 Disease & Illness
Overview
Alzheimer’s disease is typically treated after symptoms appear, despite evidence that underlying changes begin years earlier. I investigated whether early calcium dysregulation and disrupted neural oscillations could act as a primary driver of disease progression (Palop & Mucke, 2016).I developed a multi-layer framework linking calcium signaling, gene regulation, and mitochondrial dynamics. The model shows how dysregulation can increase expression of genes such as BACE1, alter neuronal communication, and promote amyloid-beta imbalance (Vassar et al., 2009).I propose two connected systems: DeepNeuroGenX, a predictive platform that analyzes biomarker patterns to identify early disease risk, and Precision Epigenetic Rebalancing (PER), which could use AAV9 delivery to rebalance gene activity as a potential treatment approach.This is important because it shifts Alzheimer’s from late stage symptom management to early, biomarker guided prevention, potentially reducing disease progression before significant brain damage occurs.
Awards (1)
- Selected for CWSF 2026
Competition history
- CWSF 2026
Related projects
ISEF · 2026
Optimizing Alzheimer's Treatment: A Spatiotemporal Agent-Based Model of Combination Therapy in the Hippocampus
CWSF · 2026
Window to the Mind: A Multi-Stage Computational Pipeline for Early Alzheimer's Intervention
ISEF · 2024
Targeting Amyloid-ß Plaques: In silico Protein Modeling of Novel Antibody for Halting Alzheimer's Disease Progression
CWSF · 2026
NeuroRegen: In-Silico Design of Dual-Action Intranasal Nanoparticle Therapy for Alzheimer’s Disease
Closest projects by meaning, across every fair and year in the corpus.